DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

13.79 -0.24 (-1.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $13.79 -1.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.34
Previous Close $14.03
Daily Range $13.65 - $14.44
52-Week Range $8.87 - $15.34
Market Cap $1.8B
P/E Ratio -11.89
Dividend (Yield) $0.00 (0.0%)
Volume 925,154
Average Daily Volume 1,413,989
Current FY EPS -$0.64

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Nektar Therapeutics (NKTR) Weak On High Volume Today

Update: AstraZeneca Moves Closer To EU Approval For Moventig

Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog

Interesting NKTR Put And Call Options For May 2015

Sector Update: Health-Care Stocks Mixed Pre-Market

Nektar Therapeutics (NKTR) Shares Cross Below 200 DMA

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 20

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

See More NKTR News...

NKTR's Top Competitors

NKTR $13.79 (-1.71%)
Current stock: NKTR
TMO $117.57 (0.84%)
Current stock: TMO
ILMN $192.58 (-0.43%)
Current stock: ILMN
WAT $110.80 (0.18%)
Current stock: WAT